Sertaconazole: pharmacology of a gynecological antifungal agent (Q34105401)

31 July 2017

1 reference

title

Sertaconazole: pharmacology of a gynecological antifungal agent (English)

1 reference

31 July 2017

1 reference

C Palacín

1

1 reference

PubMed ID

11118563

31 July 2017

C Tarragó

series ordinal

2

1 reference

PubMed ID

11118563

31 July 2017

J A Ortiz

series ordinal

3

1 reference

31 July 2017

1 December 2000

1 reference

International Journal of Gynecology and Obstetrics

31 July 2017

1 reference

31 July 2017

71 Suppl 1

1 reference

31 July 2017

S37-46

1 reference

Antifungal activity of sertaconazole in vitro against clinical isolates of Candida spp..

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Vulvovaginitis due to Candida glabrata. An emerging problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Azole resistance in Candida

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Antifungal agents in the 1990s. Current status and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

The effects of antifungal agents on the morphogenetic transformation by Candida albicans in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Pathogenesis and epidemiology of vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Comparisons of the effects of fungicidal and fungistatic antifungal agents on the morphogenetic transformation of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Few microorganisms associated with bacterial vaginosis may constitute the pathologic core: a population-based microbiologic study among 3596 pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Therapy of bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900351-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-7292(00)00351-9

1 reference

31 July 2017

1 reference

PubMed ID

11118563